✉news HealthMedicine first seen 20 h ago, last 5 h ago, peak #15
FDA to Spotlight Aging and Longevity Medicine in FARS Updates
Original: FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
The FDA plans to highlight aging and longevity medicine in upcoming updates to the Federal Acquisition Regulation Supplement (FARS), according to a report by Genetic Engineering and Biotechnology News. The move signals growing regulatory attention to treatments targeting aging itself rather than individual age-related diseases, a field attracting increased investment and research interest.
Why now: Regulatory recognition of longevity medicine is a significant development for a fast-growing biotech field.
Rank over time, top of the chart is #1. 12 snapshots from 20 h ago to 5 h ago.
Evidence
- FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates · Genetic Engineering and Biotechnology News
API: https://socialmediatrends-api.osmike.com/v1/trends/801605